Taira Hada

ORCID: 0000-0003-3426-9000 · 3 papers in corpus
2023
Diagnostic pathology ·doi:10.1186/s13000-023-01340-w

BackgroundMucinous carcinoma (MC) is a histological subtype of ovarian cancer that has a worse prognosis at advanced stages than the most prevalent histological subtype, high-grade serous carcinomas. Invasive patterns have been recognized a…

article 2021
Molecular and clinical oncology ·doi:10.3892/mco.2021.2237

The aim of the present study was to examine the clinical outcome of ovarian clear cell borderline tumor (CCBT) through pathological review for cases with clear cell carcinoma (CCC) and CCBT between 1984 and 2015 who received surgery at the …

other 2020
In vivo (Athens, Greece) ·doi:10.21873/invivo.11911

AIM: To examine the clinicopathological features of ovarian seromucinous borderline tumors (SMBTs) and compare them with those of mucinous borderline/atypical proliferative mucinous tumors (MB/APMTs). PATIENTS AND METHODS: Patients with SM…